Xylistin Injection 4.5 MIU (150 mg) contains Colistimethate Sodium, a potent polymyxin-class antibiotic used for the treatment of serious infections caused by multidrug-resistant Gram-negative bacteria. Colistimethate is particularly effective against Pseudomonas aeruginosa, Acinetobacter species, and Klebsiella species, which may not respond to conventional antibiotics.

Xylistin Injection is commonly prescribed in hospital settings for critically ill patients with infections such as ventilator-associated pneumonia, bloodstream infections, urinary tract infections, and complicated intra-abdominal infections. Its intravenous administration ensures rapid systemic action, providing targeted therapy against life-threatening bacterial infections.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

How Xylistin Injection Works

Colistimethate Sodium is a prodrug of colistin and works as a bactericidal antibiotic by disrupting the bacterial cell membrane:

• Binds to lipopolysaccharides in the outer membrane of Gram-negative bacteria

• Disrupts membrane integrity, causing leakage of cell contents and bacterial death

• Effective against multidrug-resistant strains that are resistant to other antibiotics

• Provides rapid bactericidal activity, helping control severe infections

• Administered intravenously, ensuring systemic distribution to infected tissues

This mechanism makes Xylistin Injection a critical therapy in managing infections resistant to multiple antibiotics, particularly in intensive care settings.

Indications

Xylistin Injection 4.5 MIU (150 mg) is indicated for:

• Severe infections caused by multidrug-resistant Gram-negative bacteria

• Hospital-acquired and ventilator-associated pneumonia

• Bloodstream infections (septicemia) caused by susceptible bacteria

• Complicated urinary tract infections

• Complicated intra-abdominal infections, including peritonitis

• Other serious infections where first-line antibiotics are ineffective

It is primarily reserved for patients requiring hospital-based intravenous antibiotic therapy due to the severity of infection and bacterial resistance profile.

Dosage and Administration

• The dosage of Xylistin Injection depends on patient weight, renal function, and infection severity.

• The usual adult dose is 4.5 MIU (150 mg) intravenously every 12 hours, or as directed by the physician.

• The injection should be administered slowly over 30–60 minutes, preferably via IV infusion.

• Dose adjustments are necessary for patients with renal impairment to reduce the risk of nephrotoxicity.

• Therapy duration varies based on clinical response but typically ranges from 7 to 14 days or until infection resolution.

Strict adherence to dosing and administration guidelines is crucial to maximize efficacy while minimizing toxicity.

Precautions

• Use under medical supervision in patients with renal or neuromuscular disorders.

• Monitor kidney function regularly during treatment due to the risk of nephrotoxicity.

• Use with caution in patients receiving other nephrotoxic or neurotoxic drugs.

• Not recommended for patients with known hypersensitivity to colistin or other polymyxins.

• Pregnant or breastfeeding women should use this medication only under careful medical supervision.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Common side effects include:

• Mild injection site reactions

• Fever or chills

• Nausea

Serious but rare side effects may include:

• Nephrotoxicity (kidney damage)

• Neurotoxicity, such as dizziness, numbness, or muscle weakness

• Severe allergic reactions, including rash or anaphylaxis

Immediate medical attention is required if difficulty breathing, swelling, or severe kidney dysfunction occurs.

Storage

Store Xylistin Injection 4.5 MIU (150 mg) in a cool, dry place, protected from light. Keep out of reach of children. Reconstituted solution should be used promptly as per hospital protocols.

Xylistin Injection 4.5 MIU (150 mg) provides potent and targeted treatment for serious multidrug-resistant Gram-negative infections, ensuring rapid bacterial clearance and supporting patient recovery under professional supervision.